|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/10 |
| (11) | Number of the document | 3218397 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15797815.6 |
| Date of filing the European patent application | 2015-11-13 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/060733 |
| Date | 2015-11-13 |
| (87) | Number | WO 2016/077789 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462080094 P | 2014-11-14 | US | |
| 201462087087 P | 2014-12-03 | US |
| (72) |
CORTI, Davide, CH
LANZAVECCHIA, Antonio, CH
TREFRY, John, US
SULLIVAN, Nancy, US
MULANGU, Sabue, US
GRAHAM, Barney, US
MUYEMBE-TAMFUN, Jean-Jacques, CG
LEDGERWOOD, Julie, US
STANLEY, Daphne, US
|
| (73) |
Institute for Research in Biomedicine,
Via Vincenzo Vela 6, 6500 Bellinzona,
CH
Humabs Biomed S.A., Via Mirasole 1, 6500 Bellinzona, CH The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20852-7660, US The United States Government, as represented by The Secretary of The Army, 504 Scott Street, Fort Detrick, MD 21702, US |
| (54) | NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE |
| NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE |